Literature DB >> 30988151

Two Hypervirulent Klebsiella pneumoniae Isolates Producing a bla KPC-2 Carbapenemase from a Canadian Patient.

Laura F Mataseje1, David A Boyd1, Michael R Mulvey1, Yves Longtin2.   

Abstract

This report describes two hypervirulent Klebsiella pneumoniae isolates that produced K. pneumoniae carbapenemase (KPC), which were identified from a rectal swab and a urine culture upon hospital admission. The patient had recently traveled to Greece, where he was hospitalized. The isolates were sequence type 86 and contained an IncHI1B IncFIBK hypervirulent plasmid and an IncFIIK plasmid harboring KPC.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Canada; carbapenemase; hypervirulent; plasmids

Year:  2019        PMID： 30988151      PMCID： PMC6591601          DOI： 10.1128/AAC.00517-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Emergence of tet(A) and blaKPC-2 co-carrying plasmid from a ST11 hypervirulent Klebsiella pneumoniae isolate in patient's gut.

Authors:  Danxia Gu; Huoyang Lv; Qiaoling Sun; Lingbin Shu; Rong Zhang
Journal:  Int J Antimicrob Agents       Date:  2018-06-10       Impact factor: 5.283

2.  Population-based surveillance for hypermucoviscosity Klebsiella pneumoniae causing community-acquired bacteremia in Calgary, Alberta.

Authors:  Gisele Peirano; Johann Dd Pitout; Kevin B Laupland; Bonnie Meatherall; Daniel B Gregson
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

3.  High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic Distribution, Clinical Characteristics, and Antimicrobial Resistance.

Authors:  Yawei Zhang; Chunjiang Zhao; Qi Wang; Xiaojuan Wang; Hongbin Chen; Henan Li; Feifei Zhang; Shuguang Li; Ruobing Wang; Hui Wang
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

4.  KPC-Like Carbapenemase-Producing Enterobacteriaceae Colonizing Patients in Europe and Israel.

Authors:  A Baraniak; R Izdebski; J Fiett; M Herda; L P G Derde; M J M Bonten; A Adler; Y Carmeli; H Goossens; W Hryniewicz; C Brun-Buisson; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

5.  A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study.

Authors:  Danxia Gu; Ning Dong; Zhiwei Zheng; Di Lin; Man Huang; Lihua Wang; Edward Wai-Chi Chan; Lingbin Shu; Jiang Yu; Rong Zhang; Sheng Chen
Journal:  Lancet Infect Dis       Date:  2017-08-29       Impact factor: 25.071

6.  Multilocus Sequence Types and Virulence Determinants of Hypermucoviscosity-Positive Klebsiella pneumoniae Isolated from Community-Acquired Infection Cases in Harbin, North China.

Authors:  Jizi Zhao; Jie Chen; Ming Zhao; Xiaohong Qiu; Xiaobei Chen; Wenli Zhang; Rui Sun; James Opiyo Ogutu; Fengmin Zhang
Journal:  Jpn J Infect Dis       Date:  2016-01-08       Impact factor: 1.362

Review 7.  Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding.

Authors:  Liang Chen; Barun Mathema; Kalyan D Chavda; Frank R DeLeo; Robert A Bonomo; Barry N Kreiswirth
Journal:  Trends Microbiol       Date:  2014-10-07       Impact factor: 17.079

8.  ESBL-Producing Strain of Hypervirulent Klebsiella pneumoniae K2, France.

Authors:  Laure Surgers; Anders Boyd; Pierre-Marie Girard; Guillaume Arlet; Dominique Decré
Journal:  Emerg Infect Dis       Date:  2016-09       Impact factor: 6.883

Review 9.  Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms.

Authors:  Chang-Ro Lee; Jung Hun Lee; Kwang Seung Park; Jeong Ho Jeon; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-11-21       Impact factor: 5.293

10.  First report of two rapid-onset fatal infections caused by a newly emerging hypervirulent K. Pneumonia ST86 strain of serotype K2 in China.

Authors:  Yibo Zhang; Jingyong Sun; Chenrong Mi; Wenhui Li; Shengyuan Zhao; Qun Wang; Dake Shi; Luo Liu; Bingyu Ding; Yung-Fu Chang; Hongxiong Guo; XiaoKui Guo; Qingtian Li; Yongzhang Zhu
Journal:  Front Microbiol       Date:  2015-07-21       Impact factor: 5.640
View more
  14 in total

1.  Comparative in silico characterization of Klebsiella pneumoniae hypervirulent plasmids and their antimicrobial resistance genes.

Authors:  Negin Bolourchi; Anam Naz; Maryam Sohrabi; Farzad Badmasti
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-06-02       Impact factor: 6.781

Review 2.  Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives.

Authors:  J E Choby; J Howard-Anderson; D S Weiss
Journal:  J Intern Med       Date:  2019-11-21       Impact factor: 8.989

3.  A plasmid locus associated with Klebsiella clinical infections encodes a microbiome-dependent gut fitness factor.

Authors:  Jay Vornhagen; Christine M Bassis; Srividya Ramakrishnan; Robert Hein; Sophia Mason; Yehudit Bergman; Nicole Sunshine; Yunfan Fan; Caitlyn L Holmes; Winston Timp; Michael C Schatz; Vincent B Young; Patricia J Simner; Michael A Bachman
Journal:  PLoS Pathog       Date:  2021-04-30       Impact factor: 6.823

4.  Carbapenem Resistance Conferred by OXA-48 in K2-ST86 Hypervirulent Klebsiella pneumoniae, France.

Authors:  Racha Beyrouthy; Guillaume Dalmasso; Aurélien Birer; Frédéric Robin; Richard Bonnet
Journal:  Emerg Infect Dis       Date:  2020-07       Impact factor: 6.883

5.  Genomic characterization of an emerging blaKPC-2 carrying Enterobacteriaceae clinical isolates in Thailand.

Authors:  Anusak Kerdsin; Saowarat Deekae; Sunee Chayangsu; Rujirat Hatrongjit; Peechanika Chopjitt; Dan Takeuchi; Yukihiro Akeda; Kazunori Tomono; Shigeyuki Hamada
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

6.  First Report of an Extensively Drug-Resistant ST23 Klebsiella pneumoniae of Capsular Serotype K1 Co-Producing CTX-M-15, OXA-48 and ArmA in Spain.

Authors:  Marta Hernández; Luis López-Urrutia; David Abad; Mónica De Frutos Serna; Alain A Ocampo-Sosa; José María Eiros
Journal:  Antibiotics (Basel)       Date:  2021-02-04

7.  Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.

Authors:  Negin Bolourchi; Fereshteh Shahcheraghi; Christian G Giske; Shoeib Nematzadeh; Narjes Noori Goodarzi; Hamid Solgi; Farzad Badmasti
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-10-23       Impact factor: 3.944

8.  High-Throughput Screen for Inhibitors of Klebsiella pneumoniae Virulence Using a Tetrahymena pyriformis Co-Culture Surrogate Host Model.

Authors:  Angela L Woods; David Parker; Meir M Glick; Yunshan Peng; Francois Lenoir; Evan Mulligan; Vincent Yu; Grazia Piizzi; Troy Lister; Maria-Dawn Lilly; JoAnn Dzink-Fox; Johanna M Jansen; Neil S Ryder; Charles R Dean; Thomas M Smith
Journal:  ACS Omega       Date:  2022-02-01

Review 9.  Neonatal Sepsis: The Impact of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae.

Authors:  Subhankar Mukherjee; Shravani Mitra; Shanta Dutta; Sulagna Basu
Journal:  Front Med (Lausanne)       Date:  2021-06-11

10.  Distribution, characterization, and antibiotic resistance of hypervirulent Klebsiella pneumoniae isolates in a Chinese population with asymptomatic bacteriuria.

Authors:  Jun Li; Yanbing Li; Mengli Tang; Fengjun Xia; Changhang Min; Yongmei Hu; Haichen Wang; Jingyi Zhang; Mingxiang Zou
Journal:  BMC Microbiol       Date:  2022-01-18       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.